Visualization of immune cell infiltration between AD and control group. by Wei He (131453)

BCL2 protein keeps their expression in different conditions treatment nevertheless each EML4-ALK cell modells exhibit variable expression. by Richard Junior Zapata Dongo (17912565)

Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models. by Richard Junior Zapata Dongo (17912565)

miR-1247-3p was downregulated in CRC resistant cells. by Dequan Wang (6007007)

The binding energy values of ATP, ALK inhibitors and ABT-199 to ALK were obtained from AlphaFold and modeled protein structures. by Richard Junior Zapata Dongo (17912565)

Downregulation of miR-1247-3p inhibited apoptosis and reduced chemosensitivity in cells. by Dequan Wang (6007007)

Loewe synergy-antagonism score analysis shows additive and synergistic effects after ALKi and ABT-199 combination treatment. by Richard Junior Zapata Dongo (17912565)

miR-1247-3p was downregulated in tissues of patients with CRC and was associated with prognosis and drug resistance. by Dequan Wang (6007007)

Overexpression of miR-1247-3p promoted apoptosis and inhibited resistance in drug-resistant cells. by Dequan Wang (6007007)

Data Sheet 1_Preclinical evidence and potential mechanisms of tanshinone ⅡA on cognitive function in animal models of Alzheimer’s disease: a systematic review and meta-analysis.doc... by Yuanhang Rong (19207540)

“…Risk of bias was evaluated following the Systematic Review Center for Laboratory Animal Experiments. The mean difference (MD) or standard mean difference (SMD) with 95% confidence intervals (CIs) were used to evaluate the effect of Tan ⅡA on cognitive function, neuropathology, neuroinflammation, oxidative stress, apoptosis, and neural/synaptic plasticity, with P < 0.05 considered a significant difference. …”

BCL2 antiapoptotic protein exhibits heterogeneous expression in Ba/F3 EML4-ALK^mutants. by Richard Junior Zapata Dongo (17912565)

Molecular docking showed that ABT-199 can fit into active site of ALK^Mutant. by Richard Junior Zapata Dongo (17912565)

HE staining results of cartilage tissue in different groups of rat PTOA (A: normal group, B: mild PTOA group, C: severe PTOA group). by Peng-fei Han (694841)

DIP grouping and aggregation system. by Chenxuan Zhu (22622476)

“…Total costs in the non-surgical group showed a decreasing trend post-DIP intervention (β₁ + β₃ = −3.12). …”

DIP coding logic example. by Chenxuan Zhu (22622476)

“…Total costs in the non-surgical group showed a decreasing trend post-DIP intervention (β₁ + β₃ = −3.12). …”

DIP pre-payment and provider behavior mechanism. by Chenxuan Zhu (22622476)

“…Total costs in the non-surgical group showed a decreasing trend post-DIP intervention (β₁ + β₃ = −3.12). …”

a. Positive ion mode volcanic map (color and up-regulation correlation with differential metabolites) (A) Mild PTOA Group VS Severe PTOA Group (B) Mild PTOA Group VS Normal Group (... by Peng-fei Han (694841)

Raw data_clean. by Carlos Sepúlveda (15272797)

“…Maximal oxygen consumption and ventilatory thresholds were measured using a modified Balke protocol. After initial screening, all participants performed an exercise task that involved stepping up and down on a 2-step footstool at a rate of 30 steps per minute (60 bpm) for 3 minutes.…”

Experimental design. by Carlos Sepúlveda (15272797)

“…Maximal oxygen consumption and ventilatory thresholds were measured using a modified Balke protocol. After initial screening, all participants performed an exercise task that involved stepping up and down on a 2-step footstool at a rate of 30 steps per minute (60 bpm) for 3 minutes.…”

Characterization of the participants. by Carlos Sepúlveda (15272797)

“…Maximal oxygen consumption and ventilatory thresholds were measured using a modified Balke protocol. After initial screening, all participants performed an exercise task that involved stepping up and down on a 2-step footstool at a rate of 30 steps per minute (60 bpm) for 3 minutes.…”